Aviation News
Press release distribution service
Home > Aviation News & Resources
Aviation Industry
  • Aviation News
  • Business Aviation
  • Commercial Aviation
  • Defense
  • Submit News

    Watch Aviation News

  • Airbus News
  • Airlines News
  • Airport News
  • Aviation News
  • Boeing News

  • Diarrhea-Pipeline Review H1 2018

     



    (Aviation-NewsWire.Com, August 16, 2018 ) Pharmaceutical and Healthcare disease pipeline guide Diarrhea-Pipeline Review, H1 2018, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape.

    Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.

    Get Free Sample Copy at http://www.reportsweb.com/inquiry&RW00011444226/sample

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Diarrhea-Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 6, 8, 5, 1, 22 and 4 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 2 and 5 molecules, respectively.

    Diarrhea (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

     To buy Link@ http://www.reportsweb.com/buy&RW00011444226/buy/2000

    Scope

    -The pipeline guide provides a snapshot of the global therapeutic landscape of Diarrhea (Gastrointestinal).
    -The pipeline guide reviews pipeline therapeutics for Diarrhea (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    -The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    -The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    -The pipeline guide reviews key companies involved in Diarrhea (Gastrointestinal) therapeutics and enlists all their major and minor projects.
    -The pipeline guide evaluates Diarrhea (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    -The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    -The pipeline guide reviews latest news related to pipeline therapeutics for Diarrhea (Gastrointestinal)

    For more information about this report http://www.reportsweb.com/diarrhea-pipeline-review-h1-2018

    Reasons to buy

    -Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    -Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    -Find and recognize significant and varied types of therapeutics under development for Diarrhea (Gastrointestinal).
    -Classify potential new clients or partners in the target demographic.
    -Develop tactical initiatives by understanding the focus areas of leading companies.
    -Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    -Formulate corrective measures for pipeline projects by understanding Diarrhea (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
    -Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    -Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

    Company Profile

    Actelion Pharmaceuticals Ltd
    Aegis Therapeutics LLC
    Akthelia Pharmaceuticals Ltd
    Albireo Pharma Inc
    Allergan Plc
    Anatara Lifesciences Limited
    Ardelyx Inc
    Assembly Biosciences Inc
    AzurRx BioPharma Inc
    Bharat Biotech International Ltd
    Chongqing Zhifei Biological Products Co Ltd
    Cosmo Pharmaceuticals NV
    DiscoveryBiomed Inc
    GP Pharm SA
    Miyarisan Pharmaceutical Company Ltd
    Mucosis BV (Inactive)
    Napo Pharmaceuticals Inc
    Nippon Shinyaku Co Ltd
    Novartis AG
    Pfizer Inc
    Prokarium Ltd
    RaQualia Pharma Inc
    Rebiotix Inc
    Recce Ltd
    RedHill Biopharma Ltd
    RxBio Inc
    Scandinavian Biopharma Holding AB
    Sigmoid Pharma Ltd
    Summit Therapeutics Plc
    Synthetic Biologics Inc
    Syntiron LLC
    Tasly Pharmaceutical Group Co Ltd
    Wuhan Institute of Biological Products Co Ltd



    ReportsWeb.com

    Rajat Sahni

    +1-646-491-9876

    sales@reportsweb.com

    Source: EmailWire.Com

    Source: EmailWire.com

    Aviation News & Resources

    Aviation Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Governing
    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    Press release service

    Aviation-Newswire.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2008 GroupWeb Media LLC
    GroupWeb Media Network

    Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
    | i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
    Aviation-NewsWire.Com - Newswire and Press Release service of GroupWeb Media LLC